Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
CellSolutions develops products for cytopathology sample preparation, cellular preservation and presentation, and digital automated screening with diagnostic interpretation. It serves clinical diagnostic applications, drawing on expertise in diagnostic cytopathology, clinical biochemistry, image analysis, and software engineering.
0 investors
0 investors
0 investors
0 investors
Cellular Logistics develops biological products focused on cardiac treatments, combining expertise in cell therapy and cGMP manufacturing to advance novel therapies for heart failure and interventional cardiology applications.
0 investors
0 investors
CellVax Therapeutics is a clinical-stage company developing personalized cell-based cancer immunotherapy that converts a patient's own tumor cells into antigen-presenting "Tumor Presenting Cells" to trigger a multi-neoantigen immune response. Its lead product, FK-PC101, targets high-risk prostate cancer patients after prostatectomy, with a platform intended to extend to other solid tumors.
0 investors
0 investors
0 investors
0 investors
0 investors
Centrose develops Extracellular Drug Conjugates (EDCs), a class of antibody drug conjugate that targets the cell surfaceome by binding multiple extracellular proteins without internalization, for treating cancers such as metastatic cancers and lymphomas. Its pipeline includes EDCs aimed at drug-resistant non-Hodgkin lymphoma, metastatic cancers, and other lymphoma types.
0 investors
0 investors
0 investors
Cerberus Therapeutics is a biotechnology company developing therapeutics based on nanobody technology, a tolerance induction platform, and a KappaLink platform. Its work focuses on immune tolerance and antibody-based drug development.
0 investors
0 investors
0 investors
Ceres Nanosciences develops Nanotrap particle technology, a magnetic hydrogel used to capture, concentrate, and preserve low-abundance analytes such as pathogens, proteins, and cell-free biomarkers from complex biological and environmental samples. Its products support sample preparation for molecular, proteomic, and culture-based workflows including PCR, sequencing, mass spectrometry, liquid biopsy, and wastewater surveillance.
0 investors
0 investors
Cerillo develops a research platform designed to standardize microbiome studies by addressing methodological variability and improving reproducibility. The platform serves researchers and organizations developing microbiome-based products and applications.
0 investors
Cerium Pharmaceuticals develops and commercializes medicines for rare or "orphan" diseases, including kidney disease. The company operates in the biopharmaceutical industry with a focus on the rare disease community.
0 investors
CERO develops engineered T-cell therapies that combine tumor-clearance mechanisms from both the innate and adaptive immune systems within a single cell. Its CER T-cell platform targets treatments for hematologic malignancies and solid tumors.
0 investors
Cerrx publishes online articles about menstrual and women's health topics, such as causes of blood clots during periods.
0 investors
0 investors